NEOS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.998 SEK | 0.00% |
|
0.00% | -54.64% |
| 04-25 | NeoDynamics AB Announces CFO Changes | CI |
| 04-15 | Air Astana Partner with Italy-based Neos | MT |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -54.64% | 3.01M | - | ||
| -12.03% | 19.25B | A | ||
| -37.98% | 2.96B | C+ | ||
| +23.79% | 1.96B | - | ||
| +1.29% | 1.69B | - | ||
| +33.21% | 1.27B | B+ | ||
| -14.61% | 982M | - | ||
| -20.31% | 913M | - | C- | |
| +5.30% | 801M | - | ||
| -24.34% | 630M | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- NEOD Stock
- Ratings NEOS AB